Specialized pharmacovigilance and drug safety consultant delivering strategic, science-driven safety solutions across the entire product lifecycle. I partner with pharmaceutical, biotechnology, and healthcare organizations worldwide to strengthen safety oversight, ensure global regulatory compliance, and support informed benefit–risk decision-making. My expertise helps companies maintain inspection-ready pharmacovigilance systems while protecting patient safety and advancing therapeutic innovation.
I provide Pharmacovigilance Strategy services that deliver a structured, scalable, and inspection-ready safety framework tailored to your development stage. I align regulatory requirements, risk management, signal oversight, and operational infrastructure to ensure compliance, market readiness, and sustainable lifecycle safety management.
I provide expert authoring and critical review of aggregate safety reports, including DSURs, PSURs/PBRERs, and other periodic submissions. I ensure accurate data analysis, regulatory compliance, medical consistency, and clear risk-benefit evaluation to support global health authority requirements and inspection readiness.
I deliver structured signal detection and comprehensive benefit–risk assessments to proactively identify, evaluate, and communicate emerging safety concerns. My services include signal evaluation reports, safety governance meeting support, and advanced data analysis and interpretation to ensure regulatory compliance, informed decision-making, and continuous patient safety oversight.
Our Signal Detection and Benefit-Risk Assessments Services Include:
I prepare organizations for confident regulatory inspections through structured gap assessments, SOP remediation, and proactive compliance strengthening. I provide health authority response support, documentation review, and governance alignment to ensure inspection readiness, regulatory confidence, and sustained pharmacovigilance compliance across the product lifecycle.
I deliver comprehensive pharmacovigilance and regulatory training designed to strengthen organizational competence and compliance. My programs include Operational PV Training, Risk Management & Safety Strategy Training, Aggregate Reporting Training, and Quality Systems & Compliance Training, empowering teams with practical knowledge to support inspection readiness and sustainable safety excellence.
I provide Pharmacovigilance Strategy services that deliver a structured, scalable, and inspection-ready safety framework tailored to your development stage. I align regulatory requirements, risk management, signal oversight, and operational infrastructure to ensure compliance, market readiness, and sustainable lifecycle safety management.
I provide expert authoring and critical review of aggregate safety reports, including DSURs, PSURs/PBRERs, and other periodic submissions. I ensure accurate data analysis, regulatory compliance, medical consistency, and clear risk-benefit evaluation to support global health authority requirements and inspection readiness.
I deliver structured signal detection and comprehensive benefit–risk assessments to proactively identify, evaluate, and communicate emerging safety concerns. My services include signal evaluation reports, safety governance meeting support, and advanced data analysis and interpretation to ensure regulatory compliance, informed decision-making, and continuous patient safety oversight.
Our Signal Detection and Benefit-Risk Assessments Services Include:
I prepare organizations for confident regulatory inspections through structured gap assessments, SOP remediation, and proactive compliance strengthening. I provide health authority response support, documentation review, and governance alignment to ensure inspection readiness, regulatory confidence, and sustained pharmacovigilance compliance across the product lifecycle.
I deliver comprehensive pharmacovigilance and regulatory training designed to strengthen organizational competence and compliance. My programs include Operational PV Training, Risk Management & Safety Strategy Training, Aggregate Reporting Training, and Quality Systems & Compliance Training, empowering teams with practical knowledge to support inspection readiness and sustainable safety excellence.
Explore how I have strengthened pharmacovigilance systems, enhanced regulatory compliance, and improved inspection readiness for biotech and pharmaceutical organizations. My case studies demonstrate structured safety remediation, successful audit preparation, and strategic governance implementation that reduced risk exposure and ensured Health Authority confidence across critical development milestones.
Expert perspectives on regulatory trends, inspection readiness, safety governance, and risk management strategies designed to strengthen pharmacovigilance systems and support Health Authority expectations.

Inspection- ready at all times: A Practical framework for biotech

Why Risk-Based Therapeutic-Specific Approaches are essential

From Phase I to Commercial: Building a Scalable Pharmacovigilance system
coNTACT us
Whether you are preparing for a regulatory submission, responding to a Health Authority request, or strengthening your safety systems, I am ready to assist.
+1 (617) 775-7630
monica.singh.regulatory@gmail.com
© 2025 All rights reserved to Monica Singh